Table V.
Cox regression of overall survival on cervical cancer variables.
| 95.0% CI | ||||
|---|---|---|---|---|
| Parameters | P-value | Hazard ratio | Lower | Upper |
| Age (years) | 0.071 | 1.029 | 0.997 | 1.062 |
| Histology | 0.002 | 3.576 | 1.586 | 8.063 |
| pT | 0.011 | 1.270 | 1.057 | 1.525 |
| pN | 0.045 | 2.113 | 1.016 | 4.395 |
| pM | 0.702 | 1.305 | 0.335 | 5.085 |
| Tumour grade | 0.065 | 1.717 | 0.968 | 3.048 |
| FIGO | 0.875 | 0.994 | 0.926 | 1.068 |
| E6CytIRS | 0.475 | 0.961 | 0.863 | 1.071 |
| p16CytIRS | 0.696 | 1.026 | 0.903 | 1.165 |
| p53IRS | 0.267 | 0.892 | 0.729 | 1.092 |
| p53mutIRS | 0.975 | 0.996 | 0.765 | 1.296 |
| MDM2IRS | 0.460 | 1.050 | 0.922 | 1.196 |
| Gal-3 IRS score | 0.452 | 0.937 | 0.792 | 1.109 |
CI, confidence interval; pT, pathological tumour stage; pN, pathological node stage; pM, pathological metastasis stage; FIGO, International Federation of Gynecology and Obstetrics stage; IRS, immunoreactive score; Cyt, cytoplasmic; mut, mutated; MDM2, MDM2 proto-oncogene; Gal-3, galectin-3.